A B S T R A C T A specific and reproducible double antibody radioimmunoassay for the measurement of thyroglobulin (HTg) in human serum has been developed. Since antithyroglobulin autoantibodies combine with the ["3'I] HTg tracer, antibody-positive sera were rejected for measurement. Specificity is demonstrated in that thyroid analogous such as thyroxine (T4), triiodothyronine (T3) monoiodotyrosine (MIT) and diiodotyrosine (DIT) did not crossreact. Sera previously reacted with anti-HTg-Sepharose contained no immunoassayable HTg. Finally, sera obtained from patients after total thyroid ablation for thyroid carcinoma did not contain demonstrable HTg. The sensitivity of the assay is 1.6 ng/ml, and HTg was detectable in 74% of 95 normal subjects. The mean concentration was 5.1 ng/ml ±0.49 SEM (range < 1.6-20.7 ng/ml). Day to day variation in HTg levels is large in some euthyroid subjects and nearly absent in others. HTg was detectable in 90% of the sera obtained in 23 pregnant women at delivery in whom a mean concentration of 10.1 ng/ml ±1.3 SEM was observed. The mean level for the corresponding newborn infants at birth was 29.3 ng/ml ±4.7 SEM a value significantly higher than the mean maternal HTg concentration (P < 0.001). A group of 17 thyrotoxic individuals all had elevated HTg levels; the mean for this group was 344.8 ng/ml ±90.7 SEM. In the acute phase of subacute thyroiditis HTg was also elevated in all of 12 patients, and the mean for this group was 136.8 ng/ml ±74.6 SEM.
INTRODUCTION
In the past cumbersome and semiquantitative methods based on tanned red cell hemagglutination inhibition (1, 2) or electrophoretic immunoretention (3) were used to measure a "thyroglobulin-like" substance in blood of human beings. More recently Roitt and Torrigiani (4) described a radioimmunoassay for this large protein.
Elaborate purification of their antisera was required to obtain the reported sensitivity and specificity of their assay. We wish to describe a simplified, sensitive, and specific radioimmunoassay for human serum thyroglobulin. The levels of thyroglobulin in the sera of normal subjects and in patients with hyperthyroidism and subacute thyroiditis are also described in this report.
METHODS

Buffer
The buffer used throughout unless otherwise specified, was 0.15 M NaCl-0.0035 M phosphate buffer pH 7.0, referred to as PBS. 1 
Purification of antigen
Thyroid tissue was obtained from subjects who underwent subtotal thyroidectomy for hyperthyroidism due to Graves' disease. Extraction and purification of human thyroglobulin (HTg) was performed as follows: a mixture of 2.0 ml of PBS per gram of minced tissue was stirred overnight at 4°C, and the coarse debris was then removed by gauze filtration; the filtrate was centrifuged at 1,000 X g for 10 min at 4°C to remove cellular particles. 4 ml of the supernate thus obtained was applied to a 35 X 3.5 cm Sephadex G-200 (Pharmacia, Uppsala, Sweden) column and eluted with PBS, and 3.7 ml fractions were collected. The first peak, as indicated by optical density of the fractions at 280 nm, was concentrated by negative pressure dialysis against PBS. The concentrated protein solution thus obtained was rechromatographed on a 45 X 2.1 cm Sepharose 4B (Pharmacia) column in order to remove larger and smaller constituents. Elution was performed with PBS, and 3.7 ml fractions were collected. Purified HTg appeared in the second peak. The fractions constituting the second peak ' Abbreviations used in this paper: CV, coefficient of variation; DIT, diiodotyrosine; HCT, human chorionic thyrotropin; HTg, human thyroglobulin; Huc, HTg antiserum of one rabbit; IgG, immunoglobulin G; MIT, monoiodotyrosine; PBS, phosphate-buffered saline; T3, triiodothyronine; T., thyroxine; TSH, thyroid stimulating hormone.
Preparation of labeled antigen FIGURE 1 Immunoelectrophoretic patterns. In Fig. 1 A and B the top wells contained purified HTg (employed in the assay), the bottom wells reference serum GA. The central trough contained HTg antiserum (Fig. 1 A) and anti-whole human serum (Fig. 1 B) . A well defined precipitation arc developed with HTg (top well Fig. 1 A) no precipitation line developed with reference serum GA (bottom well Fig.  1 A) . In Fig. 1 (Fig. 1A) . Anti-whole human serum on the other hand reacted only with human serum, and absence of precipitation arcs with purified HTg was noted (Fig. 1 B) . The M EDTA Na in PBS so that 3,000 cpm were added to all tubes, yielding a final count after 5 days of 2,000 cpm per tube.
First antibody (100 1.l). Antiserum Huc was used in two different dilutions. Ordinarily a dilution of 1: 100,000 (1: 500,000 final) which bound 60-70% of [1'I] HTg in the absence of unlabeled antigen was employed. In addition, when an increase in sensitivity of the assay was required a dilution of 1: 300,000 (1: 1,500,000 final) was used. With this antibody dilution 30-40%o of ["31I] HTg was bound in the absence of unlabeled antigen.
First incubation. Tubes were vortexed and incubated for 4 days at 4VC, an interval which was found to be optimal for the present assay.
Carrier (100 pul). Normal rabbit serum (Colorado Serum Co., Denver, Colo.) diluted 1: 200 was then added as a carrier to obtain suitable precipitates from which supernates could be decanted with ease.
Second antibody (200 pI). An excess of goat antirabbit gamma globulin (Pentex, Inc., Division of Miles Laboratories) was used. The optimal dilution was found to be 1: 8.
Second incubation. The tubes were vortexed and incubated overnight (18 h) at 4°C.
Centrifugation and counting. After the second incubation all tubes were centrifuged for 20 min at 1,000 X g at 4VC; supernatants and precipitates were separated and counted in an automatic spectrometer (Nuclear-Chicago Corp., Des Plaines, Ill). The concentration of thyroglobulin in samples was calculated by reading the percent of radioactivity bound from a standard curve that was constructed with reference serum GA. To evaluate nonspecific binding in the precipitate, a control tube containing no first antibody was set up for each sample, and the appropriate correction was made.
Affinity chromatography
Affinity chromatography was carried out by a modification of the method of Cuatrecasas (8) . We prepared purified
IgG from a human serum containing a high titer of antithyroglobulin antibodies by chromatography on 0-(diethylaminoethyl)-Sephadex (DEAE-Sephadex A50) (Pharmacia). Purified IgG thus obtained was then coupled to Sepharose-4B. After extensive washing, this was packed in a siliconized Pasteur pipet plugged with glass wool. A gel bed of 5 cm length was used in all studies. These small columns were again extensively washed with diluted phosphate buffer (PBS 1:10). After 100 ml of the diluted buffer had passed through the columns an 8.0 ml fraction (control fraction 0) was obtained before application of 1 ml of the test serum. After the application of the test serum, two additional 8.0 ml fractions were collected (fractions 1 and 2). These fractions were lyophilized, and each fraction was subsequently diluted in 1.0 ml of distilled water. The first fraction after the application of the serum contained the serum proteins. All fractions were assayed for their concentration of HTg. The same serum was applied to a control column containing Sepharose-4B that had been exposed in a coupling reaction to an identical concentration of IgG obtained from a serum of a normal individual free of antithyroglobulin antibodies. A solution containing a total of 15 mg. IgG was exposed in both of these coupling reactions to 20 ml of activated Sepharose-4B. IgG was measured by radioimmuno-diffusion technique (Hyland Div., Travenol Laboratories Inc., Costa Mesa, Calif.).
Serum sample
All serum samples to be assayed were tested for the i:500 1 Fig. 3 shows a typical standard curve obtained with purified HTg and with reference serum GA at two different dilutions of the antiserum Huc. The smallest amount of thyroglobulin detectable using a final dilution of 1: 500,000 was usually 6.2 ng/ml. Further dilution of the antibody (1: 1,500,000 final) allowed concentrations as low as 0.8 ng/ml to be measured.
RESULTS
Standard curve
Specificity studies
Cross-reactivity of different thyroid anaogues. This was investigated in the present assay system because human thyroglobulin has been used (9-11) as an immuno-A. I Antithyroglobulin autoantibodies. Since antithyroglobulin autoantibodies were reported to interfere with the double antibody radioimmunoassay (4) the effect of antibody-positive sera on tracer-binding was further studied. Different dilutions of antibody-positive sera were therefore introduced in the assay (Fig. 4) . Dilutions of antibody-positive sera all yielded curves which are nonparallel with reference serum GA. In addition purified human HTg-autoantibodies obtained by the method of Metzger and Edelhoch (12) were introduced in the assay instead of the antigen (HTg). Serial dilutions of this purified autoantibody bound ['I] HTg in a linear fashion. However, parallelism with the standard curve was not observed in other studies. Therefore serum samples with an autoantibody titer of 1: 5 or greater were rejected for measurement of HTg concentrations. Under these conditions HTg levels were detectable in 74% of the sera obtained from a normal population.
Further suggestive evidence of specificity came from data obtained in two patients lacking thyroid tissue.
Thyroidectomy had been performed for thyroid carcinoma more than 10 yr ago followed by several therapeutic doses of 'I. There was no detectable HTg in the sera of these patients.
Additional evidence. Additional evidence for specificity comes from the fact that the slope of the standard curve constructed with reference serum GA consistently parallels the slope of a standard HTg dose-response curve, irrespective of the concentration of first antibody used (Fig. 3) . This by itself does not constitute proof of identity of the measured substance but can be used as an operational criterion for specificity (13) .
Final and strongest evidence of specificity was obtained through affinity chromatography studies. Indeed it was reasonable to assume that a column that was constituted of Sepharose 4B-IgG antithyroglobulin should remove the majority if not all of the HTg present in the serum and that a control column packed with Sepharose 4B-IgG normal should retain little or none of the HTg present in the same test sample. When identical sera with varying concentrations of HTg were subjected to both column systems the results in Table I confirm that human autoantibodies removed HTg and that the antithyroglobulin antibody negative IgG coupled to Sepharose-4B did not do so. 
Thyroglobulin levels
Normal test sera. Determinations of HTg concentration in 95 antibody-negative samples selected from male and female blood bank donors revealed detectable HTg levels in 74% of the subjects so tested (Fig. 5) . The mean of the detectable samples was 5.1 ng/ml ±0.49 SEM with a range from 1.6 to 20.7 ng/ml. There was a significant difference between males and females in this group (P < 0.005). Of 37 males 64% had detectable levels; the mean of the detectable levels was 3.4 ng/ml ±0.42 SEM with a range of 1.6-8.0 ng/ml (n = 24). Of 58 females 81% were detectable with a mean of 6.0 ng/ml ±0.68 SEM (n = 47) and a range from 1.6 to 20.7 ng/ml. No correlation with age was found.
Determinations on samples collected daily for 15 days in two adult euthyroid males and two adult euthyroid females revealed fluctuations in three of the four subjects which were, except for one sample, within the range demonstrated in the group of 95 normals (Fig. 6) .
HTg levels in sera of pregnant women at delivery and in cord sera. HTg concentrations determined on 23 samples obtained from pregnant women at delivery revealed detectable HTg levels in 90% with a mean level of 10.1 ng/ml ±1.3 SEM and a range from 3.1 to 22.0 ng/ml (Fig. 7) . The mean for this group was significantly higher than the mean of the detectable samples in the nonpregnant control group (P < 0.02). Assay of the cord bloods of the newborn infants revealed detectable levels in 95%, and the mean concentration of HTg was 29.3 ng/ml +4.7 SEM and ranged from 4.1 to 88.0 ng/ml. The mean for the total group assigning a value of 3.0 ng/ml to the undetectable samples was significantly different from the mean of the mothers (P < 0.001). In only two instances was the HTg value for the baby lower than the respective mother.
Effect of thyroid hormone administration in euthyroid subjects. Four euthyroid adult obese male subjects were studied before and after the oral administration of Ts (Table II) . Suppression of the serum HTg levels was observed in each of these individuals.
Thyrotoxicosis. Determinations on samples from 17 thyrotoxic patients revealed a mean HTg concentration of 344.8 ng/ml ±91.0 SEM with a range of 44.0-1400.00 ng/ml (Fig. 5) . Determinations on samples collected daily on one such thyrotoxic individual showed the elevated levels to be very constant.
Subacute thyroiditis. Serum samples were collected on 12 adult women with classic symptoms of subacute thyroiditis without hyperthyroidism. Total serum thyroxine concentrations were within normal limits, and antithyroglobulin antibodies were undetectable. The samples were thyroidectomy, the parallelism of the standard curve with dilutions of a reference serum, and the dissociation between the high incidence of detectable HTg levels in our normal population and the absence of thyroglobulin autoantibodies in the same population all indicate the specificity of this assay. Further analysis using affinity chromatography showed that human IgG containing HTg autoantibodies removed HTg from the sera tested, while normal IgG did not do so. The sensitivity of the present method was greater than that of the previously reported assay; 1.6 ng/ml compared with 10 ng/ml (4) . It seems likely that greater sensitivity accounts for the observation that HTg was detectable in 74% of the normal population instead of 60% in a previous study (4) . The reason for the lower mean levels found in the normal population in the present study compared to the data reported by Roitt and Torrigiani (4) in London is a matter of speculation. It in the normal female population than in the male, but the mean HTg levels were also significantly higher in the normal female population than in the male. The mechanism and significance of this finding is not understood at the present time. In the pregnant females at term, HTg levels are detectable in 90%; identical to the 92% reported previously (17) . The mean level was statistically higher than a group of nonpregnant females. However, the newborn infants as a group demonstrated an even higher mean HTg level than the corresponding maternal group. Except for two instances, the HTg level in the newborn was invariably higher than its mother's a finding consistent with the data obtained by Hjort and Pedersen (2) . This infers that transport of HTg from mother to fetus is unlikely. Lack of transport of 'I rat Tg in either direction across the placenta was also demonstrated by Torrigiani, Doniach, and Roitt (17) . Previous studies also have indicated that TSH levels in cord blood are significantly elevated when compared to maternal TSH levels at delivery (18) . The higher HTg levels in newborn infants compared to maternal levels may be explained on this basis. The effect of human chorionic thyrotropin (HCT) on the release of HTg in the newborn is speculative, since HCT has not been measured in cord blood and has been reported by only one group of investigators in maternal blood (19) . The higher HTg levels in the pregnant subjects might be related to HCT in the maternal circulation; however, this hypothesis remains to be proven. The fact that serum HTg can be raised by exogenous TSH and suppressed by thyroid hormone administration suggests strongly that the release of this protein is TSHmediated. The elevated HTg levels observed in patients with thyrotoxic Graves' disease are consonant with a stimulatory action of such factors as LATS (20) or a recently described human thyroid-stimulating substance (21) on thyroglobulin release. Elevated HTg levels, however, cannot be considered a reflection of thyroid hyperfunction, since they are also observed in the active state of subacute thyroiditis where euthyroidism was definitely present. The demonstration of elevated HTg levels in subacute thyroiditis contrasts with the data of Torrigiani et al. (17) . The discrepancy between the studies remains unexplained since both patient populations were studied during the acute phase of their disease. At the present time the fate and significance of thyroglobulin in the circulation remains uncertain since degradation and fate of this protein is essentially unknown in man. It is unlikely that the intrinsic Ts and T4 content of thyroglobulin makes an important contribution to the total thyroid hormone economy in normal man since the HTg content is so low. Even in thyrotoxic states where extremely elevated values are encountered the possibility of such a contribution to the thyroid hormone economy would be greatly dependent on the degree of iodination of this circulating protein, and this is essentially unknown.
